Posts Tagged ‘social anxiety disorder’

Shy children now candidates for dangerous psychiatric drugs

Wednesday, October 5th, 2011

NaturalNews
By Elizabeth Walling
October 5, 2011

(NaturalNews) New guidelines for mental illness turn shyness in children from a personality trait into a mental disorder that warrants drug treatment. Drug companies already target children, who fidget too much in class or have trouble concentrating on their homework, with stimulant drugs for treating attention deficit disorder. Now children who sit too quietly or are more withdrawn than their peers will also be targeted with medication for social anxiety disorder or depression.

These new guidelines increase the likelihood that children, who tend to be quiet or sad, will be diagnosed with depression. And children who talk back to adults or lose their temper frequently may be diagnosed with what is called oppositional defiant disorder. A diagnose in either case will likely lead to treatment with powerful psychotropic drugs.

Serious Risks for Children who take Psychiatric Drugs

The idea of turning every spectrum of human emotion into some kind of mental disorder is not only absurd, but it also threatens the long-term mental and physical health of our children.

Millions of children are currently taking one or more behavior-altering medications, despite the fact that these drugs carry the risk of serious side effects. Some of these side effects include suicidal thinking, loss of appetite, nausea, insomnia, sedation, seizures, insulin resistance, acne, tremors, muscle stiffness and more.

Some psychologists also point out that simply drugging children for behaving out of the norm could actually be masking very serious underlying problems. Children, who are the victims of mental, physical or sexual abuse, will often exhibit behaviors such as shyness, sadness or being more withdrawn. These experts warn that trying to seek a quick-fix for negative emotions denies children what they truly need: long-term care and guidance.

Who stands to profit from expanding the guidelines for diagnosable mental disorders? The answer is quite simple: the pharmaceutical companies which manufacture the drugs for treating these conditions. However, when we start labeling children as disordered for simply being quieter than their peers or having an occasional angry outburst, we are stepping into dangerous territory that threatens the future of an entire generation and beyond.

Sources for this article include:

http://www.dailymail.co.uk/health/a…

http://www.telegraph.co.uk/health/h…

http://www.sciencedaily.com/release…

http://www.aboutourkids.org/article…

About the author:

Elizabeth Walling is a freelance writer specializing in health and family nutrition. She is a strong believer in natural living as a way to improve health and prevent modern disease. She enjoys thinking outside of the box and challenging common myths about health and wellness. You can visit her blog to learn more:
www.livingthenourishedlife.com/2009…

Read the article here:  http://www.naturalnews.com/033778_shy_children_psychiatric_drugs.html

« Return to news items


Share

American Psychiatric Association Slammed by Disease Mongering Parody Featuring Instant Disease Generation Engine

Wednesday, March 23rd, 2011

Saleonl.com, March 23, 2011
By Steve Diaz

click image for Disease Mongering Engine

The American Psychiatric Association is under fire today by an independent health news site’s launch of the “Disease Mongering Engine” – an online tool that allows users to instantly generate disorders, dysfunctions and syndromes that sound real, but aren’t.

Available at www.NewsTarget.com, the Disease Mongering Engine was created by Mike Adams, a vocal critic of modern psychiatric medicine and its practice of labeling healthy people with fictitious diseases, then over-medicating them with patented pharmaceuticals.

“Modern psychiatry has lost its way and has now become a marketing branch of Big Pharma,” Adams said. “Convincing healthy people that they’re diseased, then harming them with unsafe chemical medications, is not a legitimate approach to health and healing.” Diseases ranging from ADHD to Social Anxiety Disorder were “invented” by drug companies and psychiatrists, Adams says, as a way to generate billions of dollars in profits by selling treatment drugs and services to people who don’t need them.

The Disease Mongering Engine is capable of generating more than 73,000 unique disease names. Disease definitions are also generated using advanced linguistic modeling that results in real-sounding disease explanations using words and phrases found in the American Psychiatric Association’s DSM-IV, the “bible” of psychiatric disorders.

In initial testing, the engine randomly generated more than 25 disorders that are actually listed in the DSM-IV and used by psychiatrists to diagnose children and adults.

Humorous disease names generated by the Disease Mongering Engine include Repetitive Erectile Sleepwalking Dysfunction (RESD), Repetitive Manic Identity Syndrome With Anxiety (RMISWA) and Intermittent Dysmorphic Eating Dysfunction With Indigestion (IDEDWI). Users can generate more fictitious diseases at: http://www.newstarget.com/disease-mongering-engine.asp

« Return to news items


Share

Campaign to “Stop the Stigma” of Mental Illness—Is a Pharmaceutical Marketing Campaign

Monday, December 20th, 2010

The Citizens Commission on Human Rights, (CCHR) has launched a new video to expose the hypocracy of the pharmaceutically driven campaign to “Stop the Stigma” of mental illness.    With its seemingly altruistic sounding agenda to eliminate “stigma”  the fact is the real  “stigmatization” is coming from those behind this campaign—pharma, psychiatry and pharma-funded front groups such as  NAMI and CHADD to name but a few.    There are currently 20 million kids & adolescents labeled with mental “disorders” that are based solely on a checklist of behaviors, no brain scans, x-rays, genetic or blood tests can prove they are “mentally ill”,  yet they are being stigmatized with psychiatric labels, which will be part of their permanent medical record,  and prescribed dangerous, life-threatening psychiatric drugs.

Child drugging is a $4.8 billion-a-year industry, and the industry knows where to put its funding to get the most bang for its buck.    For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs. (For an in-depth look at what else Pharma funds and how this funding not only helps set mental health policies but campaigns such as this, read Pharmaceutical Industry Agenda Setting in Mental Health Policies at the bottom of this post)

The real stigmatization is coming from those that benefit from labeling behaviors as diseases to be “cured” or “treated” despite the complete lack of  medical/biological evidence to support them.  George Orwell coined the term Doublespeak, meaning words redefined to mislead, distort and disguise, and no better example exists than psychiatry’s pathologizing and redefining behaviors into mental “illness”.      For example,  If an adolescent is strong willed,  this is redefined as  “oppositional defiant disorder.” If a kid acts like a kid,   sometimes losing pencils or toys, or acting “on the go” then this has been pathologized into  “ADHD.” If a teenager has normal adolescent mood swings, then this has been repackaged as “bi-polar disorder.” And shyness?  Doesn’t exist.  It is now called  “social anxiety disorder.” Moreover, once labeled, these kids are stigmatized for life.

Psychiatric labels are the stigma.

Various canned press releases and “studies” circulated by the Psycho/Pharmaceutical industry profess,  “more people now believe that illnesses like schizophrenia and depression are caused by chemical imbalances in the brain.”  This is marketing at its best—say people believe in a chemical imbalance so you don’t have to bother pointing out the fact that there is no chemical imbalance .  How can the layperson be sure of this? It’s simple. Find one person who has a lab test showing their chemical imbalance.  Not one of the millions of people taking drugs to cure their “chemical imbalance” has a lab test showing they have an imbalance.

So when it comes to “stigmatization” one need look no further than those who benefit from labels which are simply based on opinion—not science, and not medicine. Now it really doesn’t take a rocket scientist to figure that out… does it?

Watch video: Psychiatry—Stigmatizing Kids with Bogus ‘Mental Disorders’ http://www.youtube.com/watch?v=Wv49RFo1ckQ

For more information  about pharmaceutical front groups see this:  http://www.cchrint.org/psycho-pharmaceutical-front-groups/

For an in-depth look at this topic, read Pharmaceutical Industry Agenda Setting in Mental Health Policies

« Return to news items


Share

Stop the Stigma of Mental Illness? Try Stopping the Pharma Funded Campaigns & Groups Behind the “Stigmatizing”

Friday, September 17th, 2010

(Image taken from: http://herinst.org/sbeder/corppower/pharm-agenda.html)

by CCHR Int

A new study, the result of a joint collaboration between Indiana University and Columbia University, and published  by the American Journal of Psychiatry, reports that prejudice and discrimination still exists among people with serious mental illness.  Headlines include “Mental Illness Stigma Hard to Shake, Survey Finds” and “Despite Deeper Understanding of Mental Illness, Stigma Lingers.”

So what exactly is behind this study? Taking aside the fact that Columbia University is well known for its collaboration with pharmaceutical companies, its medical center having collaborated with AstraZeneca, GlaxoSmithKline, Janssen Pharmaceutica, Merck, Novartis and Pfizer. Or the fact that Indiana University received a $1 million grant from Eli Lilly.

With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by those who benefit from more and more people being labeled mentally ill—pharma, psychiatry and pharmaceutical front groups such as  NAMI and CHADD to name but a few.   For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs. (For an in-depth look at what else Pharma funds and how this funding not only helps set mental health policies but campaigns such as this, read Pharmaceutical Industry Agenda Setting in Mental Health Policies at the bottom of this post)

The fact is that the  “stigmatization ” is coming from those that benefit from people being labeled/stigmatized with mental disorders that have no medical/biological evidence. Case in point, if you are rebellious, you are “stigmatized” with the label “oppositional defiant disorder.” If your kid acts like a kid he is “stigmatized” with the label “ADHD.” If you are sad, unhappy (even temporarily) you are “stigmatized” with the label “depressive” or “bi-polar disorder.” If you are shy you are “stigmatized” with the label “social anxiety disorder.” Moreover, you or your child are now stigmatized for life as this label, which is based solely on opinion, is now part of your medical record, despite the fact there is no medical evidence to prove you are “mentally ill”.

This is also true of people diagnosed “schizophrenic.” There is no medical test to verify someone has a brain abnormality or medical condition of schizophrenia. And while no one claims  people can’t become psychotic, the fact remains there is no biological evidence to support schizophrenia as a brain disease or chemical abnormality.  And consider this, if people do become psychotic, or irrational,  is it in fact caused by some  underlying medical (not psychiatric) problem?   And why did a 15-year multiple follow up study find that there was a 40% recovery rate for those diagnosed schizophrenic who did not take antipsychotics, versus a 5% rate for those who did?  What happened to their supposed “brain disease?” Did it simply vanish?  Moreover, if they could recover from such a mental state, do they deserve the “stigma” of “schizophrenia” still being part of their permanent medical record?  For life?   Think about it.  Imagine you were extremely overweight—obese.  You lose all the weight so you are no longer obese.  Yet your medical records continue to say that you are.

And if schizophrenia is in fact a “disease” despite the fact there is no medical or biological evidence (note we did not say speculation, or theories, but evidence) then why is it that psychiatrist Loren Mosher, the former Chief of Schizophrenia Research for the National Institute of Mental Health (NIMH) openly state that there is no biological condition of schizophrenia as a disease or brain malfunction? And why didn’t the mental health industry take advantage of his 2-year-outcome studies proving that those diagnosed schizophrenic could recover without the use of drugs? Is it because this proved that recovery was possible and thereby disproved the theory that something was wrong with their brain? Or was it the fact that they recovered without the use of drugs, thereby threatening a multi-billion dollar pharmaceutical industry?  Maybe this explains why Mosher was fired from his position at NIMH (http://www.moshersoteria.com/)

As a final note regarding “stigmatization,” keep in mind that psychiatrists admit there is no recovery from “mental illness.” They admit no cures. So once you are labeled—game over.

The new “study” also reports, ” more people now believe that illnesses like schizophrenia and depression are caused by chemical imbalances in the brain.”  This is marketing at its best—say people believe in a chemical imbalance so you don’t have to bother pointing out the fact that there is no chemical imbalance .  How can the layperson be sure of this? It’s simple. Find one person who has a lab test showing their chemical imbalance.  Not one of the millions of people taking drugs to cure their “chemical imbalance” has a lab test showing they have an imbalance.  Now it really doesn’t take a rocket scientist to figure that out… does it?

For more information  about pharmaceutical front groups see this:  http://www.cchrint.org/psycho-pharmaceutical-front-groups/

For an in-depth look at this topic, read Pharmaceutical Industry Agenda Setting in Mental Health Policies


Abstract: The development of political agenda-setting through the use of sophisticated public relations techniques is threatening to undermine the delicate balance of representative democracy. This has important ramifications for policies aimed at providing mental health services and the implementation of mental health laws. The principal agenda setters in this area are pharmaceutical companies with commercial reasons to promote public policies that expand the sales of their products. They have manufactured highly effective advocacy coalitions that incorporate front groups in order to set the policy agenda for mental health. However, policies tailored to their commercial purpose are not necessarily beneficial either for patients or the society at large.



« Return to news items


Share

The Irish Times—All in our heads: Have we taken psychiatry too far?

Friday, August 13th, 2010

by Jason Walsh

Saturday, August 14th

With drafts of the latest edition of the world’s leading psychiatry manual emerging, critics question the growing medicalisation of life’s problems

OVER THE past three decades, unhappiness has been redefined as depression, shyness has been reclassified as social anxiety disorder – even trivial complaints such as fussy eating are now being viewed through a psychiatric prism. Some of this is due to a single book, the Diagnostic and Statistical Manual , which critics claim is contributing to the ever-expanding empire of mental health. The next official edition of the DSM will be published in May 2013, but draft versions are currently doing the rounds.

Books abound on the creeping medicalisation of everyday life, television shows like In Treatment and The Sopranos revolve around endless therapy sessions, as do films by the likes of Woody Allen. According to clinical psychotherapist Áine Tubridy: “Many people’s problems have sociological causes, not medical ones. They are problems of living. Society needs to recognise that for many people life is bloody hard,” she says.

But there is growing criticism of the DSM itself and the entire model of diagnoses from within the psychiatric establishment.

Consultant psychiatrist Dr Pat Bracken, clinical director of mental health services in west Cork, is unrelenting in his criticism of over-reliance on the DSM .

“Despite being a primarily American book, the DSM is used universally. The alternative is the International Classification of Diseases published by the World Health Organisation,” he says.

“The DSM really took off in the 1980s, introducing what are called ‘operationalised definitions’. That seemed more scientific – a psychiatrist could say: ‘This person fits these diagnostic criteria.’ It introduced a new way of thinking and a focus on diagnosis.”

The criticism boils down to this: reliance on the DSM reduces psychiatry to little more than a consensus on what kind of behaviour or thoughts are abnormal, not an evidence-based analysis of what is wrong in people’s lives.

Bracken says along with the DSM ’s rise there was a corresponding demise in the use of psychotherapy within the medical profession, even if there was an expansion of private use of therapies and counselling, many of which are of dubious efficacy. For Bracken though, the medicalisation of life’s problems creates the worry that “expert” intervention in private life is often disempowering and misses the point.
“The DSM reflects a growing trend to seek ‘experts’ for problems that once wouldn’t have been the domain of the expert: gambling, social anxiety, marriage problems and so on,” says Bracken. “These were once seen as the vicissitudes of life. The demise of organised religion has also contributed to the growing social demand. The DSM legitimises that process and contributes to it,” he says.

This argument links the medical critique of the DSM back to its social implications. The repercussions of privatised social lives driven by the breakup of traditional sources of solidarity outside the family unit – organised religion, trade unions, political parties and other communal organisations – has left individuals confused, lonely and often frightened and encouraged to seek therapy when in fact the problem is a socio-political one.

What, though, is to be done when a patient arrives at their GP’s surgery in despair?

Niall Crumlish, deputy external affairs and policy director of the College of Psychiatry of Ireland, is a locum consultant psychiatrist at St James’s Hospital in Dublin. While he recognises the limitations of psychiatric diagnosis, a patient who asks for help must be given it, he says.

“There are cases for arguing that we are both over-medicalised and under-medicalised,” he says. “There is a huge number of people presenting to primary care providers [seeking psychiatric help] but there are also many not presenting, people with major depression who are functioning but at a much lower level than they might.

“Without the DSM we’d be losing a basic foundation for what we are doing. There is some validity to diagnosis. There is such a thing as a depressive syndrome that you could produce biologically if you were so minded,” he says.

An article published in the Journal of the American Medical Association this July by two of the DSM ’s authors argued the forthcoming fifth edition should be of interest to all health providers, not just psychiatrists.

The DSM is in part a product of the US psychiatric establishment being rocked in the 1960s. David Rosenhan, a follower of the controversial Scottish “anti-psychiatrist” Dr RD Laing, virtually smashed psychoanalysis as it was practised in America almost single handedly.

Rosenhan and some colleagues presented themselves at several mental hospitals claiming to have a sole auditory hallucination – a voice in their heads saying “thud” – and then behaved normally. They were all diagnosed with a variety of mental illnesses: schizophrenia and manic-depressive psychosis. They were eventually released, months later, when they “admitted” they were mentally ill and pretended to get better, demonstrating – they said – that psychiatrists were unable to distinguish between the sane and the insane.

The experiment’s objective wasn’t to prove the obvious point that it is possible to pretend to be mentally ill. Instead it demonstrated that, once admitted, all behaviour by patients is pathologised and ordinary actions were taken as evidence of illness. This rocked the establishment and one hospital challenged Rosenhan to do it again. He agreed and the hospital soon declared it had discovered 41 fakes. Rosenhan then announced he had sent no one for the second experiment.

According to Bracken, this body blow coincided with the increasing use of drug treatment for illnesses: “In the 1950s and 1960s, psychoanalysis was very dominant. Then you had a rejection of that and a move toward the DSM and the psychopharmacology revolution. “Today, the efficacy of the drugs is being called into question,” he says.

By moving away from endless psychoanalysis the diagnostic model favoured by the DSM , particularly from the 1980 third edition onwards, seemed to offer an answer to the problem. Patients symptoms were analysed on a more or less statistical basis and those who fit a specified pattern were declared to have the relevant condition.

Although it has since spread worldwide, the American bias of the DSM is clear: given that unhappiness is not covered by health insurance policies but major depression is, a massive expansion of diagnoses of depression and related illnesses is unsurprising. However, DSM critics argue the book is part of a wider reshaping of our understanding of what it is to be human, not simply a licence to malinger but pathologising everyday experiences.

Read the rest of this article here: http://www.irishtimes.com/newspaper/weekend/2010/0814/1224276782556.html

« Return to news items


Share

The Total Failure of Modern Psychiatry

Sunday, June 27th, 2010

Natural News
By David Gutierrez
June 27, 2010

Modern psychiatry went wrong when it embraced the idea that the mind should be treated with drugs, says Edward Shorter of the University of Toronto, writing in the Wall Street Journal.

Shorter studies the history of psychiatry and medicine.

Modern U.S. psychiatry has adopted a philosophy that psychological diseases arise from chemical imbalances and therefore have a very specific cluster of symptoms, he says, in spite of evidence that the difference between many so-called disorders is minimal or nonexistent. These “disorders” are then treated with expensive drugs that are no more effective than a placebo.

“Psychiatry seems to have lost its way in a forest of poorly verified diagnoses and ineffectual medications,” he writes.

Shorter calls for U.S. psychiatry to abandon its emphasis on “psychopathology” and instead adopt the European approach, which focuses on the symptoms and needs of people as individuals. Yet the draft of the latest edition of psychiatric diagnostic “Bible,” the Diagnostic and Statistical Manual of Mental Disorders (DSM), shows that U.S. psychiatry has no intention of changing course.

“With DSM-V, American psychiatry is headed in exactly the opposite direction: defining ever-widening circles of the population as mentally ill with vague and undifferentiated diagnoses and treating them with powerful drugs,” Shorter writes.

U.S. psychiatry was not always obsessed with psychopharmacology, he notes. Its early years were marked by a psychoanalytic approach that categorized mental disorders in broad, fluid categories such as “nerves,” “melancholia” or “manic-depressive illness.” These categories sufficed because similar treatments would work for people suffering from any version thereof: lithium treated both mania and severe depression, for example, while the specific symptoms experienced by an anxious person had little influence on the therapies needed.

“Our psychopathological lingo today offers little improvement on these sturdy terms,” Shorter said. “A patient with the same symptoms today might be told he has ‘social anxiety disorder’ or ‘seasonal affective disorder.’ … The new disorders all respond to the same drugs, so in terms of treatment, the differentiation is meaningless and of benefit mainly to pharmaceutical companies that market drugs for these niches.”

In the 1950s and ’60s, a new wave of psychiatrists sought to turn away from psychoanalysis — perceiving it as focusing excessively on “unconscious psychic conflicts” — and toward a more “scientific” model instead. As a result, the DSM-III introduced the vague new categories of “major depression” and “bipolar disorder,” even though evidence suggests that there is no substantial difference between the two conditions. At the same time, “major depression” absorbed what Shorter calls two very different conditions, “neurotic depression” and “melancholia.”

“This would be like incorporating tuberculosis and mumps into the same diagnosis, simply because they are both infectious diseases,” he writes.

DSM-V only continues the trend of extending the disordered label to more and more normal people, Shorter warns: “To flip through the latest draft of the American Psychiatric Association’s Diagnostic and Statistical Manual, in the works for seven years now, is to see the discipline’s floundering writ large.”

For example, the new disorder of “psychosis risk syndrome” associates a whole new class of people with full-blown schizophrenia, under the logic, Shorter says, that “even if you aren’t floridly psychotic with hallucinations and delusions, eccentric behavior can nonetheless awaken the suspicion that you might someday become psychotic.” The implication, of course, is that such people should be treated with antipsychotics.

Symptoms of “psychosis risk syndrome” include such vague descriptors as “disorganized speech.”

Other new “disorders” include hoarding, mixed anxiety-depression and binge eating. “Minor neurocognitive disorder” describes a reduction in cognitive function over time, such as that normally experienced by people over the age of 50, while “temper dysregulation disorder with dysphoria” refers to children who suffer from outbursts of temper.

“DSM-V accelerates the trend of making variants on the spectrum of everyday behavior into diseases,” Shorter says, “turning grief into depression, apprehension into anxiety, and boyishness into hyperactivity.”

Read entire article:  http://www.naturalnews.com/029088_psychiatry_failure.htmll

« Return to news items


Share

The Huffington Post— Creating Disease: Big Pharma and Disease Mongering

Sunday, June 20th, 2010

The Huffington Post
by Dr. Larry Dossey
June 18, 2010

You may think there is enough disease in the world already, and that no one would want to add to the diseases that we humans must deal with. But there is a powerful industry in our society that is working overtime to invent illnesses and to convince us we are suffering from them.

This effort is known as “disease mongering,” a term introduced by health-science writer Lynn Payer in her 1992 book Disease-Mongers: How Doctors, Drug Companies, and Insurers Are Making You Feel Sick. Payer defined disease mongering as “trying to convince essentially well people that they are sick, or slightly sick people that they are very ill.” This strategy has also been called “the corporate construction of disease” by Ray Moynihan, Iona Heath and David Henry in the British Medical Journal. “There’s a lot of money to be made from telling healthy people they’re sick,” they say. “Pharmaceutical companies are actively involved in sponsoring the definition of diseases and promoting them to both prescribers and consumers.”

Read entire article:  http://www.huffingtonpost.com/dr-larry-dossey/big-pharma-health-care-cr_b_613311.html

« Return to news items


Share

Psychiatry & the United States of Affliction: Are You Normal or Finally Diagnosed?

Wednesday, June 9th, 2010

The Diagnostic and Statistical Manual of Mental Disorders is a list that can be abused to the detriment of patients and benefit of drug companies.

Miller-McCune
By Arnie Cooper
June 8, 2010

“My dear Sir, take any road, you can’t go amiss. The whole state is one vast insane asylum.” — James L. Petigru

Spend just a few minutes watching prime time television with its endless pageant of commercials for antidepressants and anti-anxiety meds and you start to wonder if USA really means the United States of Affliction.

Such “direct to consumer” drug advertising ties into one of the most far-reaching criticisms in revising the Diagnostic and Statistical Manual of Mental Disorders: the potential to transform normal human behavior into a mental disorder.

This issue didn’t arise with the ongoing revision of the DMS-V. It’s long been a concern for psychiatry, which must exist uneasily alongside pharmaceutical companies’ hopes of expanding their markets and Americans’ desire for take-a-pill quick fixes. But past experiences suggest new diagnoses will reap a harvest of not fully intended consequences of patients larded with labels — and prescriptions.

Christopher Lane, an intellectual historian who has written extensively on psychiatry and culture, detailed the inclusion of “social anxiety disorder” in the DSM-III in his 2007 book, Shyness: How Normal Behavior Became a Sickness.

Lane revealed how the 15-member DSM-III task force, in its quest to establish psychiatry as a legitimate science (and riding the wave of drug companies looking to expand their markets for anti-psychotics and tranquilizers), spit out “almost over night” various new disorders, including one for those uncomfortable with social situations.

No longer need shyness be a variant of normal. Now it can be a neurochemical disorder addressable with GlaxoSmithKline’s multibillion-dollar marvel Paxil. Before safety concerns and patent expirations raised their ugly heads, antidepressants had become the second-largest selling class of drugs in the United States.

“In this desire to biologize and medicalize, with the idea that every personal crisis or problem is due to a disorder of the brain, we’ve lost sight of the vast complexity of behavioral responses to external stresses,” Lane says. Add to that some possibly dangerous side effects. Along with Prozac and Zoloft, Paxil was found to increase thoughts of suicide, especially among teens, prompting an FDA warning in 2004.

Read entire article:  http://www.miller-mccune.com/health/are-you-normal-or-finally-diagnosed-17073/

« Return to news items


Share

LewRockwell.com – The Big Government-Big Pharma Complex: Disease Mongering for Fear and Profit

Sunday, October 11th, 2009

Karen De Coster
LewRockwell.com
October 10, 2009

Ronit Ridberg has given the world a marvelous look into the fraudulent, Big Government-Big Pharma complex with his documentary film, Big Bucks, Big Pharma: Marketing Disease and Pushing Drugs. It’s a bit dated, from 2006, but certainly, that is no hindrance to the message of the film. It’s an hour long, but worth every minute of your time. Below, I have compiled a list of some interesting points from the film. I have also included a lot of my own thoughts from my research on issues brought up in the film, so not all of the material I have presented is contained within the documentary.

Big Pharma is a monster that’s long been out of control, and that is due to its chief enabler, big government, whose bureaucrats profit immensely from promoting Big Pharma’s agenda to grow and protect its profits. In spite of what Michael Moore would say, this arrangement is not capitalism, or as he means it, the free market. It is state capitalism, or, as some may call it, socialist corporatism.

Industry professionals discuss how Big Pharma normalizes obscure health problems, making them appear common in order to create a new market with a demand for prescription drugs. One Doc interviewed calls this “disease mongering.” For example, after the commercials appeared from GlaxoKlineSmith, suddenly everyone seemed to have Restless Leg Syndrome.

Perhaps a most disturbing trend brought up in the film is the wacky, wild world of “things just ain’t right” disorders. Whether it’s “generalized anxiety disorder,” “major depressive disorder,” “panic disorder,” “acute social phobia,” or finally, the celebrated “social anxiety disorder,” there’s a disorder to fit you and explain away your day-to-day problems.

Read entire article: http://www.lewrockwell.com/decoster/decoster165.html

« Return to news items


Share